Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $23,800 | 25 | 75.9% |
| Consulting Fee | $6,450 | 9 | 20.6% |
| Food and Beverage | $1,097 | 67 | 3.5% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $17,752 | 20 | $0 (2020) |
| W. L. Gore & Associates, Inc. | $6,450 | 9 | $0 (2024) |
| Medtronic, Inc. | $6,100 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $677.29 | 58 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $124.65 | 1 | $0 (2023) |
| Abbott Laboratories | $100.08 | 2 | $0 (2018) |
| Boston Scientific Corporation | $89.18 | 1 | $0 (2019) |
| Electromed, Inc. | $39.75 | 3 | $0 (2017) |
| Gilead Sciences, Inc. | $14.70 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,650 | 3 | Medtronic, Inc. ($1,200) |
| 2023 | $4,388 | 11 | Medtronic, Inc. ($2,600) |
| 2022 | $2,207 | 13 | Medtronic, Inc. ($1,400) |
| 2021 | $1,620 | 12 | Medtronic, Inc. ($900.00) |
| 2020 | $6,577 | 10 | Medtronic Vascular, Inc. ($5,900) |
| 2019 | $4,309 | 18 | Medtronic Vascular, Inc. ($2,900) |
| 2018 | $7,305 | 26 | Medtronic Vascular, Inc. ($5,700) |
| 2017 | $3,292 | 8 | Medtronic Vascular, Inc. ($3,252) |
All Payment Transactions
101 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| Category: Devices | ||||||
| 05/24/2024 | Medtronic, Inc. | HARMONY (Device) | — | Cash or cash equivalent | $200.00 | Research |
| Study: Harmony PAS2 • Category: Heart Valves | ||||||
| 02/16/2024 | Medtronic, Inc. | HARMONY (Device) | — | Cash or cash equivalent | $1,000.00 | Research |
| Study: Harmony PAS2 • Category: Heart Valves | ||||||
| 12/22/2023 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| Category: Devices | ||||||
| 12/06/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.70 | General |
| 08/25/2023 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Consulting Fee | Cash or cash equivalent | $675.00 | General |
| Category: Devices | ||||||
| 08/25/2023 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| Category: Devices | ||||||
| 07/28/2023 | Medtronic, Inc. | HARMONY (Device) | — | Cash or cash equivalent | $2,100.00 | Research |
| Study: Harmony PAS2 • Category: Heart Valves | ||||||
| 07/27/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/14/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: RESPIRATORY | ||||||
| 03/13/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), NUCALA | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: RESPIRATORY | ||||||
| 02/06/2023 | Medtronic, Inc. | HARMONY (Device) | — | Cash or cash equivalent | $500.00 | Research |
| Study: Harmony PAS2 • Category: Heart Valves | ||||||
| 01/17/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), NUCALA | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: RESPIRATORY | ||||||
| 12/15/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), NUCALA | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: RESPIRATORY | ||||||
| 12/07/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), NUCALA | Food and Beverage | In-kind items and services | $2.87 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), NUCALA | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: RESPIRATORY | ||||||
| 09/07/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), NUCALA | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: RESPIRATORY | ||||||
| 08/31/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), NUCALA | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: RESPIRATORY | ||||||
| 08/11/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), NUCALA | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: RESPIRATORY | ||||||
| 07/05/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), NUCALA | Food and Beverage | In-kind items and services | $4.80 | General |
| Category: RESPIRATORY | ||||||
| 06/14/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), NUCALA | Food and Beverage | In-kind items and services | $2.28 | General |
| Category: RESPIRATORY | ||||||
| 05/05/2022 | Medtronic, Inc. | HARMONY (Device) | — | Cash or cash equivalent | $1,400.00 | Research |
| Study: Harmony PAS2 • Category: Heart Valves | ||||||
| 04/22/2022 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Consulting Fee | Cash or cash equivalent | $675.00 | General |
| Category: Devices | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Harmony TPV Pivotal | Medtronic Vascular, Inc. | $17,700 | 19 |
| Harmony PAS2 | Medtronic, Inc. | $5,200 | 5 |
| Harmony TPV Pivotal | Medtronic, Inc. | $900.00 | 1 |
About Jonathan Chen
Jonathan Chen is a Thoracic Surgery (Cardiothoracic Vascular Surgery) healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972690071.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jonathan Chen has received a total of $31,347 in payments from pharmaceutical and medical device companies, with $1,650 received in 2024. These payments were reported across 101 transactions from 9 companies. The most common payment nature is "" ($23,800).
Practice Information
- Specialty Thoracic Surgery (Cardiothoracic Vascular Surgery)
- Other Specialties Surgery
- Location Seattle, WA
- Active Since 10/09/2006
- Last Updated 07/29/2013
- Taxonomy Code 208G00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1972690071
Products in Payments
- Product in Development (Device) $6,450
- HARMONY (Device) $5,200
- TRELEGY ELLIPTA (Drug) $514.29
- XARELTO (Drug) $124.65
- HeartMate 3 Left Ventricular Dev (Device) $100.08
- GENERAL ONCOLOGY (Device) $89.18
- ANORO (Drug) $58.93
- NUCALA (Biological) $54.10
- Mosaic (Device) $51.84
- SMARTVEST (Device) $39.75
- AREXVY (Drug) $38.58
- ANORO ELLIPTA (Drug) $11.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Thoracic Surgery (Cardiothoracic Vascular Surgery) Doctors in Seattle
Dr. Glenn Barnhart, Md, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) — Payments: $608,190
Eric Vallieres, Md, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) — Payments: $218,879
Dr. Eric Lehr, M.d., Phd, M.D., PHD
Thoracic Surgery (Cardiothoracic Vascular Surgery) — Payments: $88,223
Dr. Paul Hayes, Md, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) — Payments: $70,058
Douglas Wood
Thoracic Surgery (Cardiothoracic Vascular Surgery) — Payments: $23,972
Michael Mulligan, Md, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) — Payments: $21,339